HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Surbhi Malhotra-Kumar Selected Research
Surbhi Malhotra-Kumar Research Topics
Disease
12
Infections
11/2021 - 05/2009
4
Sepsis (Septicemia)
01/2020 - 01/2016
3
COVID-19
07/2022 - 10/2021
3
Ventilator-Associated Pneumonia
01/2022 - 01/2018
3
Pneumonia (Pneumonitis)
11/2021 - 08/2019
3
Respiratory Tract Infections (Respiratory Tract Infection)
11/2016 - 08/2006
2
Dysbiosis
03/2022 - 01/2021
2
Clostridium Infections
01/2021 - 01/2021
2
Wounds and Injuries (Trauma)
09/2020 - 11/2012
2
Trachoma
01/2020 - 08/2009
2
Inflammation (Inflammations)
04/2016 - 01/2016
2
Ileus
04/2016 - 01/2016
2
Urinary Tract Infections (Urinary Tract Infection)
07/2015 - 12/2014
2
Pharyngitis (Sore Throat)
05/2009 - 11/2003
1
Disease Progression
07/2022
1
Obesity
03/2022
1
Sexually Transmitted Diseases (Sexually Transmitted Disease)
02/2022
1
Neoplasms (Cancer)
11/2021
1
Critical Illness (Critically Ill)
10/2021
1
Coinfection
10/2021
1
Diarrhea
01/2021
1
Pseudomonas Infections
01/2021
1
Staphylococcal Pneumonia
11/2020
1
Pneumococcal Infections
01/2020
1
Weight Loss (Weight Reduction)
01/2020
1
Herpes Zoster
01/2020
1
Bacterial Infections (Bacterial Infection)
10/2019
1
Reinfection
08/2019
1
Common Cold
01/2018
1
Bacterial Pneumonia
03/2017
1
Autoimmune Diseases (Autoimmune Disease)
01/2017
1
Mycoses (Diseases, Fungus)
01/2017
1
Cross Infection (Nosocomial Infection)
04/2012
Drug/Important Bio-Agent (IBA)
8
Anti-Bacterial Agents (Antibiotics)
IBA
11/2021 - 04/2012
5
Cytokines
IBA
11/2021 - 01/2017
3
Interleukin-17 (Interleukin 17)
IBA
11/2021 - 01/2017
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2021
2
Interleukin-6 (Interleukin 6)
IBA
11/2021 - 01/2016
2
Amoxicillin (Wymox)
FDA Link
Generic
11/2021 - 11/2016
2
Meropenem (Merrem)
FDA Link
Generic
01/2021 - 08/2019
2
Virulence Factors (Pathogenicity Factors)
IBA
11/2020 - 03/2017
2
Azithromycin (Zithromax)
FDA Link
Generic
01/2020 - 08/2009
2
Colistin (Coly-Mycin)
FDA Link
01/2020 - 08/2019
2
Interleukin-4 (Interleukin 4)
IBA
10/2019 - 01/2018
2
DNA (Deoxyribonucleic Acid)
IBA
01/2018 - 05/2014
2
Nitrofurantoin (Macrodantin)
FDA Link
Generic
07/2015 - 12/2014
2
Fluoroquinolones
IBA
11/2012 - 05/2009
1
Monoclonal Antibodies
IBA
07/2022
1
bamlanivimab
IBA
07/2022
1
bamlanivimab and etesevimab drug combination
IBA
07/2022
1
casirivimab and imdevimab drug combination
IBA
07/2022
1
Xenobiotics
IBA
03/2022
1
Chlorogenic Acid
IBA
03/2022
1
Chemokine CCL27
IBA
11/2021
1
Chemokine CX3CL1
IBA
11/2021
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2021
1
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
11/2021
1
Chemokines
IBA
11/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2021
1
baricitinib
IBA
10/2021
1
remdesivir
IBA
10/2021
1
favipiravir
IBA
10/2021
1
tocilizumab (atlizumab)
FDA Link
10/2021
1
Mucins
IBA
10/2021
1
Messenger RNA (mRNA)
IBA
10/2021
1
Pharmaceutical Preparations
IBA
01/2021
1
beta-Lactams
IBA
01/2021
1
Carbapenems (Carbapenem Antibiotics)
IBA
01/2021
1
Local Anti-Infective Agents (Antiseptics)
IBA
09/2020
1
Povidone-Iodine (Betadine)
FDA Link
Generic
09/2020
1
Complement System Proteins (Complement)
IBA
01/2020
1
Lipopolysaccharides
IBA
01/2020
1
salicylhydroxamic acid (SHAM)
IBA
01/2020
1
Alkaline Phosphatase
IBA
01/2020
1
Interleukin-22 (IL-22)
IBA
10/2019
1
carbapenemase
IBA
08/2019
1
Interleukin-13
IBA
01/2017
1
3-(2,4-dimethoxybenzylidene)anabaseine
IBA
04/2016
1
alpha7 Nicotinic Acetylcholine Receptor
IBA
04/2016
1
Antibodies
IBA
01/2016
1
16S Ribosomal RNA
IBA
07/2015
1
RNA (Ribonucleic Acid)
IBA
05/2014
1
Ciprofloxacin (Cipro)
FDA Link
Generic
05/2009
1
Reserpine (Serpasil)
FDA Link
05/2009
1
Quinolones
IBA
08/2006
1
Bacitracin (Baci-Rx)
FDA Link
Generic
11/2003
Therapy/Procedure
3
Therapeutics
01/2021 - 11/2016
3
Punctures
01/2020 - 01/2016
3
Ligation
01/2020 - 01/2016
3
Artificial Respiration (Mechanical Ventilation)
10/2019 - 01/2018
1
Bathroom Equipment
02/2022
1
Duration of Therapy
11/2021
1
Complementary Therapies (Alternative Medicine)
11/2020
1
Mass Drug Administration
01/2020
1
Medical Day Care (Partial Hospitalization)
01/2018
1
Splenectomy
04/2016
1
Catheters
01/2016
1
Central Venous Catheters
01/2016